Skip to main content

Table 1 Demographic and clinical characteristics of patients with different grades of cervical lesions

From: HIV gp120/Tat protein-induced epithelial–mesenchymal transition promotes the progression of cervical lesions

  

Age (years)

CIN stage

Lymphocyte count (1 × 109 cells/l)

CIN (I–III stages)

HIV- (n = 64)

36.74 ± 10.03

I

22

1.938 ± 0.533

II

28

II

14

HIV+ (n = 54)

40.21 ± 11.75

I

19

1.717 ± 0.531

II

20

III

15

Statistics

1.591

0.745

1.667

P

0.115

0.689

0.100

  

Age (years)

Cervical cancer stages

Lymphocyte count (1 × 109 cells/l)

Cervical cancer (I–II stages)

HIV− (n = 22)

44.73 ± 10.02

I

16

1.839 ± 0.542

II

6

HIV+ (n = 26)

44.05 ± 9.41

I

15

1.742 ± 0.617

II

11

Statistics

− 0.213

1.178

− 1.498

p

0.833

0278

0.135

  1. HIV human immunodeficiency virus, CIN cervical intraepithelial neoplasia
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us